# Biochemical osteomalacia during pregnancy or lactation: an observational study in Sweden

**Authors:** Thomas Torstensson, Per Kristiansson, Paul Kalliokoski

PMC · DOI: 10.1186/s12884-026-08848-1 · BMC Pregnancy and Childbirth · 2026-02-24

## TL;DR

This study found that Somali women in Sweden are at high risk for biochemical osteomalacia during pregnancy or lactation due to vitamin D deficiency, while Swedish women are less affected.

## Contribution

The study provides new prevalence data on biochemical osteomalacia in pregnant and lactating women of Somali and Swedish origin in Sweden.

## Key findings

- 1.4% of Swedish women and 34.6% of Somali women met the criteria for biochemical osteomalacia.
- Most Somali women with biochemical osteomalacia also showed clinical symptoms.
- The study highlights the need for noninvasive diagnostic criteria and further research on vitamin D deficiency in high-risk groups.

## Abstract

Studies of osteomalacia during pregnancy and lactation are scarce. This is likely due to the hazards of performing X-ray in pregnancy, the inconvenience of the gold standard diagnostic procedure of bone marrow biopsy with histomorphometry and the lack of these resources in maternity health care. Another important reason is the lack of international consensus on how to diagnose osteomalacia clinically. Osteomalacia needs attention due to the limited number of modern studies on its prevalence and globalization, especially in some populations where migration to high latitudes with poor light conditions, as in Scandinavia, can heighten its prevalence. The aim of this study was to determine the prevalence of biochemical osteomalacia during pregnancy or lactation among Somali and Swedish women living in Sweden.

This was an observational cohort study of 71 Swedish and 52 Somali pregnant or lactating women. Blood samples, self-report questionnaires and physical examination data were collected in late spring. The diagnostic criteria for biochemical osteomalacia were serum levels of a 25-hydroxy vitamin D3 (25(OH)D) concentration < 30 nmol/L, a parathyroid hormone (PTH) concentration > 6.9 pmol/L and an alkaline phosphatase (ALP) concentration > 1.8 ukat/L. The presence of clinical symptoms (grip weakness, leg weakness, a positive Trendelenburg test, fatigue, and pain) was used to reaffirm the diagnosis.

The diagnostic criteria for biochemical osteomalacia were met by one Swedish woman 1/71 (1.4%) and 18/52 (34.6%) of all Somali women, of whom 1/71 (1.4%) and 16/52 (30.8%), respectively, had signs or symptoms reaffirming the diagnosis.

Women of Somali origin living at high altitudes are at high risk for vitamin D deficiency osteomalacia, but Swedish women may also suffer from this disease. These findings call for further studies on the prevalence of vitamin D deficiency, especially among groups at risk of vitamin D deficiency, because of the hidden disease burden. Establishing internationally accepted criteria for a noninvasive clinical diagnostic procedure for osteomalacia is imperative.

ClinicalTrials.gov Identifier: NCT02922803. Date of registration: September 28, 2016.

The online version contains supplementary material available at 10.1186/s12884-026-08848-1.

## Linked entities

- **Diseases:** osteomalacia (MONDO:0001068)

## Full-text entities

- **Genes:** PTH (parathyroid hormone) [NCBI Gene 5741] {aka FIH1, PTH1}, ALPP (alkaline phosphatase, placental) [NCBI Gene 250] {aka ALP, PALP, PLAP, PLAP-1}, PTHLH (parathyroid hormone like hormone) [NCBI Gene 5744] {aka BDE2, HHM, PLP, PTHR, PTHRP}, KHDRBS3 (KH RNA binding domain containing, signal transduction associated 3) [NCBI Gene 10656] {aka Etle, SALP, SLM-2, SLM2, T-STAR, TSTAR}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}
- **Diseases:** vitamin D deficiency (MESH:D014808), Fatigue (MESH:D005221), seizures (MESH:D012640), fragility fractures (MESH:D005600), mental or somatic disorders (MESH:D013001), Pain (MESH:D010146), fractures (MESH:D050723), Grip weakness (MESH:D018908), tenderness (MESH:D063806), weakness of hip abductors (MESH:C536354), femoral fracture (MESH:D005264), hypocalcemia (MESH:D006996), malabsorption (MESH:D008286), micronutrient deficiencies (MESH:D007153), endocrine and neurological disorders (MESH:D004700), Osteomalacia (MESH:D010018), hypophosphatemic (MESH:C564145)
- **Chemicals:** tetracyclines (MESH:D013754), copper (MESH:D003300), blood glucose (MESH:D001786), Vitamin D (MESH:D014807), zinc (MESH:D015032), phosphate (MESH:D010710), vitamin B12 (MESH:D014805), calcitriol (MESH:D002117), 1,25(OH)2D (MESH:C097949), Calcium (MESH:D002118), manganese (MESH:D008345), glucose (MESH:D005947), magnesium (MESH:D008274), S (MESH:D013455), 25-hydroxy vitamin D3 (MESH:D002112), 25(OH)D (-), tetracycline (MESH:D013752), 25 hydroxy vitamin D (MESH:C104450), mineral (MESH:D008903)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12955220/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12955220/full.md

---
Source: https://tomesphere.com/paper/PMC12955220